Table 2 The Univariate and Multivariate Analysis for METTL2A in BRCA
| Â | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
Hazard ratio | CI 95 | P Value | Hazard ratio | CI 95 | P value | |
BRCA | ||||||
 Age | 2.03 | 1.34–3.07 | 8.00E−04 | 2.02 | 1.31–3.11 | 0.0014 |
 T stage | 1.43 | 1.11–1.84 | 0.0052 | 1.18 | 0.89–1.56 | 0.2485 |
 N stage | 1.52 | 1.22–1.9 | 2.00E−04 | 1.28 | 0.98–1.68 | 0.0746 |
 M stage | 5.79 | 2.99–11.21 |  < 0.0001 | 2.53 | 1.11–5.74 | 0.0269 |
ER status | 0.95 | 0.59–1.53 | 0.8301 |  |  |  |
PR status | 0.83 | 0.55–1.27 | 0.3992 |  |  |  |
HER2 status | 0.99 | 0.54–1.81 | 0.9649 |  |  |  |
METTL2A | 1.4 | 1–1.97 | 0.0496 | 1.44 | 1–2.06 | 0.0482 |